TAT Technologies Ltd

TATT

TAT Technologies Ltd (TATT) specializes in providing maintenance, repair, and overhaul services for military and commercial aerospace and defense equipment. The company offers solutions for aircraft systems, avionic components, and other defense-related technologies, serving both civilian and military clients worldwide.

$40.20 +0.10 (0.25%)
Dividend Yield 0.85%
Payout Frequency Yearly

Dividend History

Pay DateAmountEx-DateRecord Date
June 21, 2017$0.342017-06-052017-06-07
August 9, 2016$0.342016-07-252016-07-27
May 7, 2014$0.232014-04-212014-04-23
May 17, 2012$0.282012-05-012012-05-03
December 7, 2009$0.302009-11-192009-11-23

Dividends Summary

Company News

Viridian Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
GlobeNewswire Inc. • Johnson Fistel, Pllp • March 31, 2026

Johnson Fistel, PLLP announced investigations into potential securities law violations by Viridian Therapeutics, Braskem S.A., and TAT Technologies Ltd. on behalf of investors who suffered losses. The investigation into Viridian focuses on whether the company complied with federal securities laws following its announcement of Phase 3 clinical tri...

TAT Technologies Reports Second Quarter 2025 Results
Benzinga • Prnewswire • August 11, 2025

TAT Technologies reported strong Q2 2025 financial results, with revenues increasing 18% to $43.1 million, gross profit up 35.6% to $10.8 million, and net income rising 31.5% to $3.4 million. The company sees continued growth potential in aerospace and defense markets.

50 Biggest Movers From Yesterday
Benzinga • Lisa Levin • May 20, 2021

Gainers MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday. Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) surged 23.8% to close at $102.63. Reata Pharmaceuticals announced that it received a communication from the Division of Neurology Products 1 of th...

Mid-Afternoon Market Update: Dow Falls 1%; Iovance Biotherapeutics Shares Plunge
Benzinga • Lisa Levin • May 19, 2021

Toward the end of trading Wednesday, the Dow traded down 1.08% to 33,693.98 while the NASDAQ fell 0.66% to 13,215.41. The S&P also fell, dropping 0.94% to 4,088.99. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,997,870 cases with around 587,220 deaths. India confirmed a total of at least 25,...

35 Stocks Moving In Wednesday's Mid-Day Session
Benzinga • Lisa Levin • May 19, 2021

Gainers Advaxis, Inc. (NASDAQ: ADXS) shares jumped 43.1% to $0.6943 after jumping over 14% on Tuesday. MoSys, Inc. (NASDAQ: MOSY) shares gained 32% to $5.00. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) gained 18% to $97.76. Reata Pharmaceuticals announced that it received a communication from the Division of Neurology Products 1 of the FDA, stati...

Related Companies